Global Patent Index - EP 0863770 A4

EP 0863770 A4 20010110 - CONTRAST MEDIUM AND ITS USE

Title (en)

CONTRAST MEDIUM AND ITS USE

Title (de)

KONTRASTMEDIUM UND DESSEN VERWENDUNG

Title (fr)

MILIEU DE CONTRASTE ET SON UTILISATION

Publication

EP 0863770 A4 20010110 (EN)

Application

EP 96916620 A 19960524

Priority

  • IL 11392695 A 19950531
  • US 9607666 W 19960524

Abstract (en)

[origin: WO9638183A1] Contrast medium comprising an effective amount of a contrast agent and a protecting agent wherein the protecting agent is active in protecting against possible damaging effects of the contrast medium.

IPC 1-7

A61K 49/00; A61K 49/04

IPC 8 full level

A61K 45/06 (2006.01); A61K 49/00 (2006.01); A61K 49/04 (2006.01); G01N 33/48 (2006.01)

CPC (source: EP)

A61K 45/06 (2013.01); A61K 49/0002 (2013.01); A61K 49/0452 (2013.01); G01N 33/48 (2013.01)

Citation (search report)

  • [X] US 2191118 A 19400220 - ARNOLD SALOMON
  • [X] WO 9510306 A1 19950420 - ALLIANCE PHARMA [US]
  • [E] WO 9635429 A1 19961114 - SCHERING AG [DE], et al
  • [X] US 5019370 A 19910528 - JAY MICHAEL J [US], et al
  • [A] US 2870063 A 19590120 - LA MATER GEORGE B DE
  • [A] EP 0354836 A1 19900214 - GUERBET SA [FR]
  • [A] US 3984571 A 19761005 - CHEN JAMES LING
  • [X] FEINBERG S J ET AL: "HEMODYNAMIC FUNCTION IN DOGS WITH CHRONIC OBSTRUCTIVE JAUNDICE EFFECTS OF RADIOCONTRAST MEDIUM", JOURNAL OF SURGICAL RESEARCH 1990, vol. 49, no. 1, 1990, pages 55 - 61, XP000892197, ISSN: 0022-4804
  • [X] CANTLEY LLOYD G ET AL: "Role of endothelin and prostaglandins in radiocontrast-induced renal artery constriction.", KIDNEY INTERNATIONAL 1993, vol. 44, no. 6, 1993, pages 1217 - 1223, XP000892177, ISSN: 0085-2538
  • [X] AGMON YORAM ET AL: "Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat.", JOURNAL OF CLINICAL INVESTIGATION, vol. 94, no. 3, 1994, pages 1069 - 1075, XP000892176, ISSN: 0021-9738
  • [X] CLAYTON D.G. ET AL: "Cardiovascular response during cerebral angiography under general and local anaesthesia", ANAESTHESIA, 1989, VOL. 44, NO. 7, PAGE(S) 599-602, XP000929807
  • [X] ADAMS MD ET AL: "A rat EEG model for evaluating contrast media neurotoxicity.", INVESTIGATIVE RADIOLOGY, SEP 1988, VOL. 23 SUPPL 1, PAGE(S) S217-S219, XP000929806
  • [T] SCHMIT DB ET AL: "Safe ex vivo coronary angiography with isosmotic contrast agent.", JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, AUG 1996, VOL. 112, NO. 2, PAGE(S) 306-9, XP000929773
  • [X] MURPHY D.J.: "Cerebrovascular permeability after meglumine iothalamate administration", NEUROLOGY, 1973, VOL. 23, NO. 9, PAGE(S) 926-936, XP000929853
  • [X] DOUST, BRUCE D. ET AL: "Effects of dextran infusion, glucose infusion, and state of hydration on cerebral toxicity of arteriographic contrast media", RADIOLOGY, 1972, VOL. 103, NO. 3, PAGE(S) 607-9, XP000929792
  • [X] HOEM NO ET AL: "Effects of intravenous radiographic contrast media on the blood pressure and on factors of the contact activation system in the rat.", ACTA PHARMACOLOGICA ET TOXICOLOGICA, SEP 1986, VOL. 59, NO. 3, PAGE(S) 189-94, XP000929789
  • [A] AINSWORTH J ET AL: "The arteriographic appearances following the use of intra-arterial vasodilator agents in occlusive arterial disease.", CLINICAL RADIOLOGY, OCT 1967, VOL. 18, NO. 4, PAGE(S) 439-44, XP000929786
  • See references of WO 9638183A1

Designated contracting state (EPC)

AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

DOCDB simple family (publication)

WO 9638183 A1 19961205; AU 5930996 A 19961218; AU 707118 B2 19990701; CA 2222429 A1 19961205; EP 0863770 A1 19980916; EP 0863770 A4 20010110; IL 113926 A0 19950831; IL 113926 A 20000601

DOCDB simple family (application)

US 9607666 W 19960524; AU 5930996 A 19960524; CA 2222429 A 19960524; EP 96916620 A 19960524; IL 11392695 A 19950531